This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors - Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for this market. The report profiles 102 companies including many key and niche players such as Advanced Enzymes Technologies Ltd., Ajeet Seeds Ltd., Anthem BioSciences Pvt. Ltd., Bharat Biotech International Limited, Bharat Serums and Vaccines Ltd., Biocon Limited, Syngene International Limited, Dr. Reddy's Laboratories Ltd., Ecron Acunova, Eli Lilly and Company (India) Pvt. Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Indian Immunologicals Ltd., Jubilant Life Sciences Limited, Krishidhan Seeds Private Limited, Lambda Therapeutic Research Ltd., Mahyco, Max Neeman, Monsanto, Novo Nordisk India Pvt. Ltd., Novozymes South Asia Pvt. Ltd., Nuziveedu Seeds Pvt. Ltd., Ocimum Biosolutions Ltd., Panacea Biotec Ltd., Piramal Healthcare Limited, Quintiles India, Rasi Seeds (P) Ltd., Reliance Life Sciences, Serum Institute of India Ltd., Shantha Biotechnics Limited, SIRO Clinpharm, Strand Life Sciences, Veeda Clinical Research Limited, and Vimta Labs Limited. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
Browse more Pharmaceutical Market Research Reports